USANA director gets 1,058 shares from RSU vesting

USANA Health Sciences director Frederic J. Winssinger reported the vesting and conversion of 1,058 restricted stock units into an equal number of USANA common shares on January 22, 2026.

Accepted by SEC EDGAR 01/26/2026 - 03:30 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

USANA Health Sciences director Frederic J. Winssinger reported the vesting and conversion of 1,058 restricted stock units into an equal number of USANA common shares on January 22, 2026. These shares were acquired at a stated price of $0 per share, reflecting the nature of restricted stock units as equity awards rather than open‑market purchases.

After this transaction, Winssinger directly held 7,044 shares of USANA common stock and 1,057 restricted stock units. The footnotes explain that each restricted stock unit represents the right to receive one share of common stock, and that this RSU grant vests in four 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Insider Trade Summary

1,058 shares exercised/converted

Exercise 2 txns

Insider Winssinger Frederic J

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,058	$0.00	$0.00
Exercise	Common Stock	1,058	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 1,057 contracts (Direct); Common Stock — 7,044 shares (Direct)

Holdings Before and After: Restricted Stock Units, 2,115 to 1,057 contracts (Direct); Common Stock, 5,986 to 7,044 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. F2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did USANA (USNA) report for Frederic J. Winssinger?

USANA director Frederic J. Winssinger reported the vesting and conversion of 1,058 restricted stock units into 1,058 shares of USANA common stock on January 22, 2026, at a stated price of $0 per share.

How many USANA (USNA) common shares does Frederic J. Winssinger hold after this Form 4?

Following the reported transaction, Frederic J. Winssinger directly owns 7,044 shares of USANA common stock, as disclosed in the filing.

What happens to the restricted stock units in this USANA (USNA) Form 4?

1,058 restricted stock units converted into the same number of common shares, leaving 1,057 restricted stock units beneficially owned by Frederic J. Winssinger after the transaction.

How do the USANA (USNA) restricted stock units for Frederic J. Winssinger vest?

The filing states that the restricted stock units vest in four 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Was this USANA (USNA) Form 4 transaction an open-market purchase or sale?

The transaction is coded M, reflecting the conversion of restricted stock units into common stock at a stated price of $0 per share, rather than an open-market purchase or sale.

Is Frederic J. Winssinger a director or officer of USANA (USNA)?

The filing identifies Frederic J. Winssinger as a director of USANA Health Sciences, Inc., with the Form 4 filed for one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Winssinger Frederic J

(Last) (First) (Middle)

2944 N 44TH STREET

SUITE 250

(Street)

PHOENIX AZ 85018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		M		1,058	A	(1)	7,044	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/22/2026		M			1,058	(2)	(2)	Common Stock	1,058	$0	1,057	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.